Vanda Pharmaceuticals buy StockNews.com
Start price
30.03.24
/
50%
€3.92
Target price
30.03.25
-
Performance (%)
8.67%
End price
31.03.25
€4.26
Summary
This prediction ended on 31.03.25 with a price of €4.26. With a performance of 8.67%, the BUY prediction by StockNews_com for Vanda Pharmaceuticals closed with a slight gain. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Vanda Pharmaceuticals | -5.697% | -5.697% | 39.378% |
| iShares Core DAX® | -1,86 % | 0,67 % | 0,92 % |
| iShares Nasdaq 100 | -3,32 % | 4,99 % | 33,72 % |
| iShares Nikkei 225® | -2,30 % | 6,13 % | 52,96 % |
| iShares S&P 500 | -1,31 % | 3,40 % | 24,67 % |
Comments by StockNews_com for this prediction
In the thread Vanda Pharmaceuticals diskutieren
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for VNDA provided by MarketBeat
In the thread Trading Vanda Pharmaceuticals
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten